Evaluation of Bayesian estimation of pharmacokinetic parameters

Therapeutic Drug Monitoring

Volumn 27, Issue 1, 2005, Pages 18-24

  Tsuchiwata, Shinichi ^a   Mihara, Kiyoshi ^a   Yafune, Akifumi ^b   Ogata, Hiroyasu ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b Clinic Sendagaya   (Japan)

Author keywords

Accuracy; MAP Bayesian method; Posterior distribution; Reliability

Indexed keywords

ACCURACY; ARTICLE; BAYES THEOREM; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MONITORING; PARAMETER; PRIORITY JOURNAL; PROBABILITY;

BAYES THEOREM; HUMANS; INFUSIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; TIME FACTORS;

EID: 13244279353     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200502000-00005     Document Type: Article

References (17)

1. D'Argenio DZ. Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm. 1981;9:739-756.
2. Lunn DJ, Best N, Thomas A, et al. Bayesian analysis of population PK/PD models: general concepts and software. J Pharmacokinet Pharmacodyn. 2002;29:271-307.
3. Sheiner LB, Beal S, Rosenberg B, et al. Forecasting individual pharmacokinetics. Clin Pharmacol Ther. 1979;26:294-305.
4. Thomson AH, Whiting B. Bayesian parameter estimation and population pharmacokinetics. Clin Pharmacokinet. 1992;22:447-467.
5. Hurst AK, Iseri KT, Gill MA, et al. Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis. Clin Pharm. 1987;6:234-238.
6. Okamoto MP, Chin A, Gill MA, et al. Comparison of two microcomputer Bayesian pharmacokinetic programs for predicting serum gentamicin concentrations. Clin Phrmaco;. 1990;9:708-711.
7. Kaufmann GR, Vozeh S, Wenk M, et al. Safety and efficacy of a two-compartment Bayesian feedback program for therapeutic tobramycin monitoring in the daily clinical use and comparison with a non-Bayesian one-compartment model. Ther Drug Monit. 1998;20:172-180.
8. Wu G, Baraldo M, Pea F, et al. Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods. Pharmacol Res. 1995;32:355-362.
9. Higuchi S, Yukawa E, Aoyama T. Bayesian prediction of serum phenytoin concentration in a simulation study. Chem Pharm Bull (Tokyo). 1988;36:1914-1918.
10. Proost JH. Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting. Int J Clin Pharmacol Ther. 1995;33:531-536.
11. Denaro CP, Ravenscroft PJ. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients. Br J Clin Pharmacol. 1989;28:37-44.
12. Wu G, Pea F, Cossettini P, et al. Effect of the number of samples on Bayesian and non-linear least-squares individualization: a study of cyclosporin treatment of haematological patients with multidrug resistance. J Pharm Pharmacol. 1998;50:343-349.
13. Yafune A, Ishiguro M, Kitagawa G. Kullback-leibler information approach to the optimum measurement point for Bayesian estimatation. Commun. Stat. Theory Meth. 1996;25:519-536.
14. Beal SL, Sheiner LB (Eds.). NONMEM users guides. NONMEM project group University of California, San Francisco, CA, 1992.
15. Jelliffe RW, Schumitzky A, Guilder MV, et al. Indivisualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Ther Drug Monit. 1993;15:380-393.
16. Retout S, Mentre F. Optimization of individual and population designs using Splus. J Pharmacokinet Pharmacodyn. 2003;30:417-443.
17. Retout S, Mentre F. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981;9:503-512.